Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac failure and benzodiazepines

C Guilleminault1, A Clerk, M Labanowski

  • 1Stanford University Sleep Disorders Clinic and Research Center, California 94304.

Sleep
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moxifloxacin-induced rhabdomyolysis.

Intensive care medicine·2012
Same author

A Method of Extracting the Petrous Bone for a post Mortem Examination of the Ear.

British medical journal·2010
Same author

Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

British journal of pharmacology·2008
Same author

Severe ST depression due to hypokalemia mimicking ischaemia.

The Journal of the Association of Physicians of India·2005
Same author

Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment.

Sleep medicine·2005
Same author

An animal model of a spontaneously reversible obstructive sleep apnea syndrome in the monkey.

Neurobiology of disease·2005

Benzodiazepine hypnotics improved sleep fragmentation and duration in cardiac failure patients. However, they did not affect respiratory disturbances, and nasal CPAP worsened breathing.

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Pharmacology

Background:

  • Patients with stable cardiac failure often experience sleep disturbances.
  • Benzodiazepine hypnotics are commonly prescribed but their effect on sleep and respiration in cardiac failure is not fully understood.

Purpose of the Study:

  • To investigate the effects of a benzodiazepine hypnotic on sleep fragmentation and respiratory disturbances in patients with stable cardiac failure.
  • To compare the efficacy of benzodiazepine therapy with nasal CPAP in managing sleep and respiratory issues in this population.

Main Methods:

  • Nine patients with stable cardiac failure and reduced ejection fraction were studied.
  • Sleep and respiratory parameters were monitored under three conditions: no medication, nasal CPAP, and benzodiazepine therapy.

Related Experiment Videos

  • Key metrics included arousal index, total sleep time, sleep efficiency, and respiratory disturbance index (RDI).

    • Main Results:

    • Benzodiazepine therapy significantly reduced the arousal index and improved total sleep time and sleep efficiency.
    • Nasal CPAP was ineffective in improving disordered breathing and worsened respiratory parameters.
    • Benzodiazepine treatment did not significantly affect central hypopneas or apneas (RDI).

    Conclusions:

    • Benzodiazepine hypnotics can improve sleep quality in cardiac failure patients.
    • Nasal CPAP may not be effective and could potentially worsen respiratory function in some cardiac failure patients.
    • Further research is needed to understand the complex interplay between cardiac failure, sleep, and respiratory interventions.